Literature DB >> 34626322

Racial Disparities in Total Joint Arthroplasty.

Danielle S Chun1, Annemarie K Leonard1, Zenaida Enchill1, Linda I Suleiman2.   

Abstract

PURPOSE OF REVIEW: The primary aim of this review was to evaluate recently published total joint arthroplasty (TJA) studies in order to accurately summarize the current concepts regarding racial and ethnic disparities in total joint arthroplasty. RECENT
FINDINGS: Many studies found that racial and ethnic disparities in TJA are present in all phases of arthroplasty care including access to, utilization of, and postoperative outcomes after TJA. Factors that limit patient access to TJA-increased patient comorbidities, lower socioeconomic status, and Medicaid/uninsured status-are also disproportionately associated with underrepresented patient populations. Minority patients are more likely to require more intensive postoperative rehabilitation and non-home discharge placement. This in turn potentially adds additional concerns regarding hospital/provider reimbursement in light of the current Medicare/Medicaid model for arthroplasty surgeons, thus creating a recurrent cycle in which disparities in TJA reflect the complex interplay of overall health disparities and access inequalities associated with racial and ethnic biases. Literature demonstrating evidenced-based interventions to minimize these disparities is sparse, but the multifactorial cause of disparities in TJA highlights the need for multifaceted solutions on both a systemic and individual level.
© 2021. The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature.

Entities:  

Keywords:  Racial disparities; Total hip replacement; Total joint replacement; Total knee replacement

Year:  2021        PMID: 34626322      PMCID: PMC8733080          DOI: 10.1007/s12178-021-09718-3

Source DB:  PubMed          Journal:  Curr Rev Musculoskelet Med        ISSN: 1935-9748


  38 in total

1.  Do Geographic Region, Medicaid Status, and Academic Affiliation Affect Access to Care Among Medicaid and Privately Insured Total Hip Arthroplasty Patients?

Authors:  Adam M Almaguer; Alan R Hsu; Jeffrey M Pearson; Haley M McKissack; James R Jones; Sameer M Naranje; Ashish B Shah
Journal:  J Arthroplasty       Date:  2019-08-02       Impact factor: 4.757

2.  Persistent Racial Disparities in Utilization Rates and Perioperative Metrics in Total Joint Arthroplasty in the U.S.: A Comprehensive Analysis of Trends from 2006 to 2015.

Authors:  Troy B Amen; Nathan H Varady; Sean Rajaee; Antonia F Chen
Journal:  J Bone Joint Surg Am       Date:  2020-05-06       Impact factor: 5.284

Review 3.  Updated Projected Prevalence of Self-Reported Doctor-Diagnosed Arthritis and Arthritis-Attributable Activity Limitation Among US Adults, 2015-2040.

Authors:  Jennifer M Hootman; Charles G Helmick; Kamil E Barbour; Kristina A Theis; Michael A Boring
Journal:  Arthritis Rheumatol       Date:  2016-07       Impact factor: 10.995

4.  The Impact of Hospital Volume on Racial Differences in Complications, Readmissions, and Emergency Department Visits Following Total Joint Arthroplasty.

Authors:  Muyibat A Adelani; Matthew R Keller; Robert L Barrack; Margaret A Olsen
Journal:  J Arthroplasty       Date:  2017-09-25       Impact factor: 4.757

5.  Do Patient Point of Entry and Medicaid Status Affect Quality Outcomes Following Total Knee Arthroplasty?

Authors:  James E Feng; Mackenzie A Roof; Mohamed Adnan; Afshin A Anoushiravani; Scott Friedlander; Claudette M Lajam; Jonathan Vigdorchik; James D Slover; Ran Schwarzkopf
Journal:  J Arthroplasty       Date:  2020-02-17       Impact factor: 4.757

6.  Unmet Need for Total Joint Arthroplasty in Medicaid Beneficiaries After Affordable Care Act Expansion.

Authors:  Christopher J Dy; Abigail R Barker; Derek S Brown; Matthew Keller; Peter Chang; Ken Yamaguchi; Margaret A Olsen
Journal:  J Bone Joint Surg Am       Date:  2020-09-02       Impact factor: 5.284

7.  Eligibility Criteria for Lower Extremity Joint Replacement May Worsen Racial and Socioeconomic Disparities.

Authors:  Abigail Y Wang; Michelle S Wong; Casey Jo Humbyrd
Journal:  Clin Orthop Relat Res       Date:  2018-12       Impact factor: 4.176

8.  Preventing Hospital Readmissions and Limiting the Complications Associated With Total Joint Arthroplasty.

Authors:  Stephen Yu; Kevin L Garvin; William L Healy; Vincent D Pellegrini; Richard Iorio
Journal:  J Am Acad Orthop Surg       Date:  2015-11       Impact factor: 3.020

9.  Obesity in Total Hip Arthroplasty: Demographic Disparities and Outcome Incongruities.

Authors:  Wayne A Wilkie; Ethan A Remily; Nequesha S Mohamed; Scott McDermott; Bernard Shalit; Andrew Baird; Kenneth Brand; James Nace; Ronald Delanois
Journal:  Cureus       Date:  2020-05-04

10.  Disparity of health services in patients with knee osteoarthritis before total knee arthroplasty.

Authors:  Hunter Warwick; Jonathan O'Donnell; Richard C Mather; William Jiranek
Journal:  Arthroplast Today       Date:  2020-01-08
View more
  4 in total

1.  Have all races experienced reductions in complication rates following total hip arthroplasty? A NSQIP analysis between 2011 and 2019.

Authors:  Daniel Grits; Christian J Hecht; Alexander J Acuña; Robert J Burkhart; Atul F Kamath
Journal:  Eur J Orthop Surg Traumatol       Date:  2022-09-17

2.  CORR Synthesis: How Might the Preoperative Management of Risk Factors Influence Healthcare Disparities in Total Joint Arthroplasty?

Authors:  Chloe C Dlott; Daniel H Wiznia
Journal:  Clin Orthop Relat Res       Date:  2022-03-18       Impact factor: 4.755

Review 3.  Time to Reflect and Take Action on Health Disparities and Health Inequities.

Authors:  Susan Salmond; Caroline Dorsen
Journal:  Orthop Nurs       Date:  2022 Mar-Apr 01       Impact factor: 0.913

4.  Patients' perspectives on the benefits of feedback on patient-reported outcome measures in a web-based personalized decision report for hip and knee osteoarthritis.

Authors:  Brocha Z Stern; Sarah Pila; Layla I Joseph; Nan E Rothrock; Patricia D Franklin
Journal:  BMC Musculoskelet Disord       Date:  2022-08-23       Impact factor: 2.562

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.